Clinical Trials Related to Chronic Inducible Urticaria

Related studies linked through entity extraction aliases.

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults

Status: RECRUITING
Phase: PHASE1

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

Status: RECRUITING
Phase: PHASE3

A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria

Status: RECRUITING
Phase: PHASE1

Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)

Status: RECRUITING
Phase: PHASE2

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria

Status: COMPLETED
Phase: PHASE2

A Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- Antihistamines

Status: TERMINATED
Phase: PHASE1/PHASE2

Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria

Status: COMPLETED
Phase: PHASE1

A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases

Status: COMPLETED
Phase: PHASE1

A Study of CDX-0159 in Patients With Chronic Inducible Urticaria

Status: COMPLETED
Phase: PHASE2

Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines

Status: TERMINATED
Phase: PHASE3